在胃肠道癌症中等离子体状细胞的多方面的功能:潜在的治疗目标?
Frederik J Hansen1, Paul David1, Georg F Weber1
1Department of General and Visceral Surgery, Medical Faculty of Friedrich-Alexander-University Erlangen, University Hospital Erlangen, 91054 Erlangen, Germany.
Cancers
|June 27, 2024
概括
等离子体树突细胞 (pDCs) 在胃肠道瘤中具有复杂的作用,有时阻碍,有时帮助抗瘤免疫力. 针对pDCs显示出对新型癌症治疗的希望.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 胃肠道 (GI) 瘤是一个重大的全球健康挑战.
- 等离子体树突细胞 (pDCs) 是关键的免疫细胞,在瘤免疫中具有双重作用,可能促进或抑制癌症的进展.
研究的目的:
- 审查pDCs在各种胃肠道癌症中的多样性作用.
- 评估pDCs作为GI恶性瘤的潜在治疗标.
主要方法:
- 文献综述总结了关于胃肠道瘤中pDCs的现有研究.
- 分析pDC透及其与不同肠胃癌类型患者结果的相关性.
主要成果:
- 在胃癌,肝细胞癌和肝脏内胆血管癌中,较高的pDC透与较差的结果相关.
- 相反,在食道癌,胰腺癌和结直肠癌中,pDC存在与改善的结果有关.
- 胃癌和肝细胞癌的临床前研究表明,pDC可以有效地针对治疗.
结论:
- pDC对胃肠道瘤产生多方面的影响,影响抗瘤反应和瘤的进展.
- 进一步的研究对于优化pDC向疗法和开发组合治疗策略至关重要.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Tumor Immunotherapy
510
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
510


